Menu
Ramin Goudarzi, Pharm.D, MBA
President
Dr. Goudarzi leads Pharmin USA and the Division of Research and Development. He manages a global team of safety officers to ensure the safety of all Pharmin throughout the entire life cycle. Dr. Goudarzi is responsible for company research designs, safety surveillance practices as well as leadership in ensuring the highest medical standard, approaches to clinical data transparency and scientific integrity.
Research Interests :
Using different models of connective tissue injuries, Dr. Goudarzi employs an integrative approach to examine the role of second messengers in controlling joint and skin inflammation and pain. He applies genomics approaches to measure biomarkers’ activities in osteoarthritis and psoriasis. His team’s main goal is to identify novel therapeutic agents to help relieve joint and skin disease, inflammation and pain. To this date, the team was able to engineer currently available Arthrocen®, topical Rocen ® and Decalciterol ® helping numbers of osteoarthritis and psoriatic patients.
Research Topics :
– Signal transduction
– Inflammation
– Nociception
– Musculoskeletal disorders
– Pain
Education & Training :
The University of Iowa, School of Medicine, Department of Pharmacology,
Postdoctoral Research Fellowship, Signal Transduction, Iowa
Postdoctoral Research Fellowship, Signal Transduction, Iowa
The University of Iowa, School of Medicine, Department of Pharmacology, Postdoctoral Research Fellowship, Signal Transduction, Iowa
National University, College of Management and Technology,
Master of Business Administration, Entrepreneurship and Strategy, San Jose
Master of Business Administration, Entrepreneurship and Strategy, San Jose
National University, College of Management and Technology, Master of Business Administration, Entrepreneurship and Strategy, San Jose
San Francisco General Hospital Medical Center,
Internship, Internal Medicine, San Fransisco
Internship, Internal Medicine, San Fransisco
San Francisco General Hospital Medical Center, Internship, Internal Medicine, San Fransisco
Tehran University of Medical Sciences,
School of Pharmacy, Pharmacy Doctorate, Tehran
School of Pharmacy, Pharmacy Doctorate, Tehran
Tehran University of Medical Sciences, School of Pharmacy, Pharmacy Doctorate, Tehran
Selected Honor :
Former Member of Iran Basketball National Team
Selected Publications :
Joint Dysfunctionality Alleviation along with Systemic Inflammation
Reduction Following Arthrocen Treatment in Patients with Knee
Osteoarthritis: A Randomized Double-Blind Placebo-Controlled Clinical
Trial. Goudarzi R, Thomas P, Ryan S., Medicina (Kaunas). 2022 February
Reduction Following Arthrocen Treatment in Patients with Knee
Osteoarthritis: A Randomized Double-Blind Placebo-Controlled Clinical
Trial. Goudarzi R, Thomas P, Ryan S., Medicina (Kaunas). 2022 February
Joint Dysfunctionality Alleviation along with Systemic Inflammation Reduction Following Arthrocen Treatment in Patients with Knee Osteoarthritis: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Goudarzi R, Thomas P, Ryan S., Medicina (Kaunas). 2022 February
Phosphatidylserine liposomes containing curcumin inhibit bone
loss in osteoporotic rats: A possible synergy through a common signaling
pathway. Partoazar A, Goudarzi R., J Food Biochem. 2022 July
loss in osteoporotic rats: A possible synergy through a common signaling
pathway. Partoazar A, Goudarzi R., J Food Biochem. 2022 July
Phosphatidylserine liposomes containing curcumin inhibit bone loss in osteoporotic rats: A possible synergy through a common signaling pathway. Partoazar A, Goudarzi R., J Food Biochem. 2022 July
Nanomedicine and regenerative medicine approaches in osteoarthritis therapy.
Goudarzi R, Dehpour AR, Partoazar A., Aging Clin Exp Res. 2022 October
Goudarzi R, Dehpour AR, Partoazar A., Aging Clin Exp Res. 2022 October
Nanomedicine and regenerative medicine approaches in osteoarthritis therapy. Goudarzi R, Dehpour AR, Partoazar A., Aging Clin Exp Res. 2022 October
Management of Osteoarthritis with Avocado/Soybean Unsaponifiables
Christiansen BA, Bhatti S, Goudarzi R, Emami S., Cartilage 2015 January
Christiansen BA, Bhatti S, Goudarzi R, Emami S., Cartilage 2015 January
Management of Osteoarthritis with Avocado/Soybean Unsaponifiables Christiansen BA, Bhatti S, Goudarzi R, Emami S., Cartilage 2015 January
Evaluation of the novel avocado/soybean unsaponifiable Arthrocen to alter
joint pain and inflammation in a rat model of osteoarthritis
Goudarzi R, Reid A, McDougall JJ, Plos One. 2018 February
joint pain and inflammation in a rat model of osteoarthritis
Goudarzi R, Reid A, McDougall JJ, Plos One. 2018 February
Evaluation of the novel avocado/soybean unsaponifiable Arthrocen to alter joint pain and inflammation in a rat model of osteoarthritis Goudarzi R, Reid A, McDougall JJ, Plos One. 2018 February
Effects of Arthrocen, an avocado/soy unsaponifiables agent, on inflammatory
mediators and gene expression in human chondrocytes.
Goudarzi R, Taylor JF, Pedersen BA., FEBS Open Bio, January 2017
mediators and gene expression in human chondrocytes.
Goudarzi R, Taylor JF, Pedersen BA., FEBS Open Bio, January 2017
Effects of Arthrocen, an avocado/soy unsaponifiables agent, on inflammatory mediators and gene expression in human chondrocytes. Goudarzi R, Taylor JF, Pedersen BA., FEBS Open Bio, January 2017
To view the list of all publications, click HERE.
To view the list of all publications, click HERE.
Affiliations :
American College of Rheumatology
Arthritis Foundation
American College of Pharmacy
Osteoarthritis Research Society International
International Association for the Study of Pain
Arthritis Foundation
American College of Pharmacy
Osteoarthritis Research Society International
International Association for the Study of Pain
Positions :
President, Pharmin USA, LLC
Editorial board, Journal of Current Medicine
Pharmacy preceptor/pharmacotherapy
Registered Pharmacist
Editorial board, Journal of Current Medicine
Pharmacy preceptor/pharmacotherapy
Registered Pharmacist